Zoetis’ antibody therapy, CYTOPOINT®, already approved in the EU for the treatment of clinical manifestations of atopic dermatitis in dogs now has wider application. December 3, 2020 &n...
Continue reading...
Additional Flexibility For Veterinarians As Cytopoint® Use Extended To Cover The Treatment...
Discussion in 'Veterinary News' started by Admin, Dec 3, 2020.
XenPorta 2 PRO
© Jason Axelrod from 8WAYRUN.COM